Beta Blockers
Beta blockers, also known as beta-adrenergic blocking agents, are compounds that block the action of epinephrine (adrenaline) on beta receptors, slowing the heart rate and reducing blood pressure. They are often used to treat conditions such as hypertension, arrhythmias, and heart failure. At CymitQuimica, we offer a variety of beta blockers for research purposes in cardiovascular and clinical studies.
Subcategories of "Beta Blockers"
Products of "Beta Blockers"
Sort by
Dexamethasone-17-ketone (9α-Fluoro-11β-hydroxy-16α-methylandrosta-1,4-diene-3,17-dione)
CAS:Controlled ProductFormula:C20H25FO3Color and Shape:NeatMolecular weight:332.41N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine Methyl Ester Hydrochloride
CAS:Formula:C20H22N2O2·ClH4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde Hydrochloride
CAS:Controlled ProductFormula:C13H19NO3·ClHColor and Shape:NeatMolecular weight:273.76(S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic Acid
CAS:Controlled ProductFormula:C16H16O4Color and Shape:NeatMolecular weight:272.30rac 4-Hydroxydebrisoquine-13C,15N2 Hemisulfate
CAS:Controlled ProductApplications A labelled metabolite of Debrisoquine Sulfate, a potent antihypertenvise agent. References Idle, J.R., et al.: Br. J. Clin. Pharmacol., 7, 257 (1979),Formula:C10H13N3OColor and Shape:NeatMolecular weight:191.235’-Hydroxyphenyl Carvedilol
CAS:Applications A metabolite of Carvedilol (C184625). It is used in the treatment of hypertension. References Sponer, G., et al.: J. Cardiovasc. Pharmacol., 9, 317 (1987), Fujimaki, M., ET AL.: Xenobiotica, 20, 1025 (1990), Ruffolo, R., et al.: Eur. J. Clin. Pharmacol., 38, S82 (1990), Schaefer, W.H., et al.: Drug Metab. Dispos., 26, 10, 958 (1998),Formula:C24H26N2O5Color and Shape:NeatMolecular weight:422.47Carvedilol Bisalkylpyrocatechol Impurity
CAS:Controlled ProductApplications A new known impurity of Carvedilol (C184625), published in Carvedilol USP monograph.Formula:C40H42N4O6Color and Shape:NeatMolecular weight:674.78Timolol EP Impurity H
CAS:Formula:C13H24N4O3SColor and Shape:White To Off-White SolidMolecular weight:316.42rac-Talinolol
CAS:Controlled ProductApplications Selective β1-adrenergic blocker structurally related to Practolol. Antihypertensive; antiarrhythmic. References Assmann, I., et al.: Curr. Med. Res. Opin., 13, 325 (1995), Trausch, B., et al.: Biopharm. Drug Dispos., 16, 403 (1995),Formula:C20H33N3O3Color and Shape:White To Light PinkMolecular weight:363.49N-Benzyl-tert-butylamine
CAS:Controlled ProductFormula:C11H17NColor and Shape:NeatMolecular weight:163.26Diltiazem N-desmethyl hydrochloride
CAS:Formula:C21H24N2O4S·ClHColor and Shape:NeatMolecular weight:436.951-Methylethyl 2-[[2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate
CAS:Color and Shape:NeatNebivolol Impurity 27 HCl (RR,SR)
CAS:Formula:C22H25F2NO4·HClColor and Shape:White To Off-White SolidMolecular weight:405.44 36.46Methyl 4'-(Bromomethyl)biphenyl-2-carboxylate
CAS:Controlled ProductFormula:C15H13BrO2Color and Shape:NeatMolecular weight:305.173-[3-Acetyl-4-[(2RS)-3-(diethylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea
CAS:Formula:C20H33N3O4Ubiquinol
CAS:Stability Light Sensitive, Temperature sensitive Applications Reduced coenzyme Q for improving nervous system cell functions. References Ernst, A., et al.: Archives Biochem. Biophys., 421, 54 (2004),Formula:C59H92O4Color and Shape:Off-White To OrangeMolecular weight:865.36R-(+)-alpha-Methyl-4-nitrobenzylamine
CAS:Controlled ProductFormula:C8H10N2O2Color and Shape:NeatMolecular weight:166.177Carteolol HCl EP Impurity H HCl
CAS:Formula:C16H22N2O3·HClColor and Shape:White To Off-White SolidMolecular weight:290.36 36.46(2R,3R)-2,3-Bis(benzoyloxy)butanedioic Acid (Dibenzoyltartric Acid)
CAS:Controlled ProductFormula:C18H14O8Color and Shape:NeatMolecular weight:358.30Triamcinolone acetonide
CAS:Controlled ProductFormula:C24H31FO6Color and Shape:NeatMolecular weight:434.505-[4'-[[2-Butyl-4-chloro-5-[[(triphenylmethyl]oxy]methyl]-1H-imidazol-1-yl]methyl]biphenyl-2-yl]-1H-tetrazole
CAS:Formula:C41H37ClN6OColor and Shape:NeatMolecular weight:665.23Cerivastatin Sodium Salt
CAS:Controlled ProductStability Hygroscopic Applications Cerivastatin is a competitive inhibitor of HMG-CoA reductase. References Ness, C.G., et al.: Arch. Biochem. Biophys., 325, 242 (1996), Steinke, W., et al.: Japan. Pharmacol. Ther., 24, Suppl. 9, S1217 (1996),Formula:C26H33FNO5·NaColor and Shape:White To Off-WhiteMolecular weight:481.539-Fluoro-11β,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione
CAS:Controlled ProductFormula:C22H29FO4Color and Shape:NeatMolecular weight:376.461-(2,4,6-Trimethoxybenzyl)piperazine Dihydrochloride
CAS:Controlled ProductFormula:C14H22N2O3ClHColor and Shape:NeatMolecular weight:339.26Amlodipine EP Impurity A (Amlodipine USP Related Compound D)
CAS:Controlled ProductFormula:C28H27ClN2O7Color and Shape:NeatMolecular weight:538.98A 769662
CAS:Controlled ProductApplications A 769662 is an AMP-activated protein kinase (AMPK) activiator. A 769662 selectively activates cardiac AMPK heterotrimeric complexes contg. α2/β1-subunits. References Timmermans, A.D., et. al.: Am. J. Phys., 306, H1619 (2014)Formula:C20H12N2O3SColor and Shape:NeatMolecular weight:360.39Valsartan
CAS:Stability Hygroscopic Applications A nonpeptide angiotensin II AT1-receptor antagonist. Antihypertensive. References Criscione, L., et al.: Brit. J. Pharmacol., 110, 761 (1993), Muller, P., et al.: Eur. J. Clin. Pharmacol., 47, 231 (1994)Formula:C24H29N5O3Color and Shape:NeatMolecular weight:435.52Benazeprilat
CAS:Controlled ProductFormula:C22H24N2O5Color and Shape:White To Off-WhiteMolecular weight:396.44Carteolol HCl EP Impurity A
CAS:Formula:C9H11NO2Color and Shape:Off-White SolidMolecular weight:165.191-Formyl-4-(2,3,4-trimethoxybenzyl)piperazine Hydrochloride
CAS:Controlled ProductFormula:C15H22N2O4·ClHColor and Shape:NeatMolecular weight:330.814-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde Hydrochloride
CAS:Formula:C13H19NO3·ClHPravastatin Lactone
CAS:Controlled ProductStability Hygroscopic Applications Pravastatin Lactone is a metabolite of Pravastatin (P702000). References Boberg, M., et al.: Drug Metab. Dispos., 25, 321 (1997), Neuvonen, P., et al.: Clin. Pharmacol. Ther., 63, 332 (1998), Boyd, R., et al.: J. Clin. Pharmacol., 40, 91 (2000),Formula:C23H34O6Color and Shape:NeatMolecular weight:406.51rac Timolol Maleate
CAS:Controlled ProductApplications Antihypertensive; antiarrhythmic (class II); antianginal; antiglaucoma agent. References Wasson, et al.: J. Med. Chem., 15, 651 (1972), Franciosa, et al.: Clin. Pharmacol. Ther., 13, 138 (1972), Heel, R.C., et al.: Drugs, 17, 38 (1979), Rofman, B.A., et al.: Hypertension, 2, 643 (1980), Mazzo, D.J., et al.: Anal. Profiles Drug Subs., 16, 641 (1987),Formula:C13H24N4O3S·C4H4O4Color and Shape:NeatMolecular weight:432.494”-trans-Hydroxy Cilostazol
CAS:Controlled ProductApplications A metabolite of Cilostazol. References de Morais, S., et al.: J. Biol. Chem., 269, 15419 (1994), Tata, P; J Pharm Biomed Anal 2001, 24, 381 ,Hiratsuka, M; Eur J Clin Pharmacol 2002, 58, 417 ,,Roy, J; Drug Metab Dispos 2005, 33, 884Formula:C20H27N5O3Color and Shape:NeatMolecular weight:385.46
![4-[(2RS)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb-webp%2FMM0027.24.webp&w=3840&q=75)
![1-Methylethyl 2-[[2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb-webp%2FMM0505.07-0025.webp&w=3840&q=75)
![5-Ethyl 7-Methyl 6-(2-Chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-1,4-benzo[b][1,4]oxazine-5,7-di…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb-webp%2FMM0383.15-0025.webp&w=3840&q=75)
![5-[4'-[[2-Butyl-4-chloro-5-[[(triphenylmethyl]oxy]methyl]-1H-imidazol-1-yl]methyl]biphenyl-2-yl]-1…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb-webp%2FMM0168.17-0025.webp&w=3840&q=75)
